PATENT CLAIM ANALYSIS

Application Number: 15766426
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "426000"]

Abstract:
The present invention provides a pharmaceutical composition and the like comprising (4-{(3S)-3-[(1R)-1-(naphthalen-1-yl)ethylamino]pyrrolidin-1-yl}phenyl)acetic acid (Compound A) or a pharmacologically acceptable salt thereof and a diluent.

Claim (Index 8):
The pharmaceutical composition of  claim 7 , wherein the basic additive is at least one selected from the group consisting of magnesium oxide, magnesium hydroxide, aluminum hydroxide, sodium carbonate, potassium carbonate, magnesium carbonate, calcium carbonate, sodium hydrogencarbonate, calcium silicate and magnesium aluminometasilicate.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 91.0
- Lexical Diversity: 1.2973
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14825036', '11527501', '13968776', '12355143', '12161787']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7633083259572776
- 35 USC 102 Novelty (BERT): 0.5057099371524291
- Combined Prediction Score: 0.7375484870767928
- Mean Citation Score: 205.200412
- Max Citation Score: 212.06197000000003
- Similarity Product: 128.5841430569399

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test